AI assistant
Sending…
RESMED INC — Director's Dealing 2024
Nov 14, 2024
30071_dirs_2024-11-14_711316c5-a99d-4057-a52a-fefeb291b88e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-11-12
Reporting Person: De Witte Jan (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-12 | ReMed Common Stock | S | 796 | $248.81 | Disposed | 6723 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 2, 2024.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29